Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Capreomycin sulfate
Drug ID BADD_D00351
Description Cyclic peptide antibiotic similar to viomycin. It is produced by Streptomyces capreolus.
Indications and Usage Used in the treatment of tuberculosis in combination with other drugs.
Marketing Status approved
ATC Code J04AB30
DrugBank ID DB00314
KEGG ID D00135
MeSH ID D002207
PubChem ID 135965856
TTD Drug ID D06EZI
NDC Product Code Not Available
UNII 9H8D3J7V21
Synonyms Capreomycin | Capromycin | Capreomycin Sulfate | Capastat
Chemical Information
Molecular Formula C50H92N28O23S2
CAS Registry Number 11003-38-6
SMILES CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCNC(=N2)N)CNC(=O)CC(C CCN)N.C1CNC(=NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(C CCN)N)CO)N)N.OS(=O)(=O)O.OS(=O)(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abscess11.01.08.001---
Abscess sterile08.01.05.008---
Blood urea increased13.13.01.006---
Body temperature increased13.15.01.001---
Bromosulphthalein test abnormal13.03.04.021---
Deafness04.02.01.001---
Dermatitis23.03.04.002---
Electrolyte imbalance14.05.01.002---
Eosinophilia01.02.04.001--
Hepatocellular injury09.01.07.008---
Hypersensitivity10.01.03.003--
Hypocalcaemia14.04.01.004--
Hypokalaemia14.05.03.002--
Hypomagnesaemia14.04.02.001--
Injection site haemorrhage08.02.03.005; 12.07.03.005; 24.07.01.010---
Injection site induration08.02.03.007; 12.07.03.007---
Injection site pain08.02.03.010; 12.07.03.011---
Leukocytosis01.02.01.002--
Leukopenia01.02.02.001---
Liver disorder09.01.08.001---
Nephritis20.05.02.001---
Nephropathy toxic12.03.01.010; 20.05.03.002---
Oliguria20.01.03.004---
Ototoxicity04.03.01.004; 12.03.01.012---
Pain08.01.08.004--
Pyrexia08.05.02.003--
Rash23.03.13.001---
Rash maculo-papular23.03.13.004--
Renal failure20.01.03.005---
Renal tubular necrosis20.01.07.003---
The 1th Page    1 2    Next   Last    Total 2 Pages